相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3
Ni-Chung Lee et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2022)
Promising Effect of High Dose Ambroxol Treatment on Neurocognition and Motor Development in a Patient With Neuropathic Gaucher Disease 2
Charlotte Aries et al.
FRONTIERS IN NEUROLOGY (2022)
Early initiation of ambroxol treatment diminishes neurological manifestations of type 3 Gaucher disease: A long-term outcome of two siblings
Danijela Petkovic Ramadza et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2021)
Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsy
Yoon-Myung Kim et al.
JOURNAL OF MEDICAL GENETICS (2020)
Ambroxol improves skeletal and hematological manifestations on a child with Gaucher disease
Wenjun Jiang et al.
JOURNAL OF HUMAN GENETICS (2020)
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations A Nonrandomized, Noncontrolled Trial
Stephen Mullin et al.
JAMA NEUROLOGY (2020)
Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
Tae-Un Han et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review
Shoshana Revel-Vilk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects
Yoo-Mi Kim et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial
Elena Lukina et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Effect of Ambroxol chaperone therapy on Glucosylsphingosine (Lyso-Gb1) levels in two Canadian patients with type 3 Gaucher disease
Behshad Charkhand et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2019)
Clinical and molecular characteristics of patients with Gaucher disease in Southern China
Yuyu Feng et al.
BLOOD CELLS MOLECULES AND DISEASES (2018)
Genotypes and phenotypes in 20 Chinese patients with type 2 Gaucher disease
Lulu Kang et al.
BRAIN & DEVELOPMENT (2018)
Successful newborn screening for Gaucher disease using fluorometric assay in China
Lulu Kang et al.
JOURNAL OF HUMAN GENETICS (2017)
Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naive and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials
Deborah Elstein et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Gaucher disease: Progress and ongoing challenges
Pramod K. Mistry et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients
Bouwien E. Smid et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
Aya Narita et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Commentary on Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease by Zimran et al.
Ozlem Goker-Alpan
BLOOD CELLS MOLECULES AND DISEASES (2013)
The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice
Zhuo Luan et al.
BRAIN & DEVELOPMENT (2013)
Revised recommendations for the management of Gaucher disease in children
Paige Kaplan et al.
EUROPEAN JOURNAL OF PEDIATRICS (2013)
Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease
Ari Zimran et al.
BLOOD (2011)
Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience
Ari Zimran et al.
BLOOD (2010)
Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
Gustavo H. B. Maegawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Gaucher disease among Chinese patients: Review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles
Francis Y. M. Choy et al.
BLOOD CELLS MOLECULES AND DISEASES (2007)
Epidemiology and natural history of Gaucher's disease
Atul Mehta
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2006)
Mutation analysis of Gaucher disease patients in Taiwan:: High prevalence of the RecNciI and L444P mutations
Lei Wan et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: A report from the Gaucher Registry
NJ Weinreb et al.
AMERICAN JOURNAL OF MEDICINE (2002)
The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease
G Altarescu et al.
JOURNAL OF PEDIATRICS (2001)
分享论文
